Halozyme Therapeutics, Inc.'s functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.
| Comparison | HALO peer score | |
|---|---|---|
|
Halozyme Therapeutics, Inc. vs UCB SA
|
50 | Compare → |
|
Halozyme Therapeutics, Inc. vs Arista Networks, Inc.
|
56 | Compare → |
|
Halozyme Therapeutics, Inc. vs Veeva Systems Inc.
|
55 | Compare → |
|
Halozyme Therapeutics, Inc. vs Gaztransport & Technigaz SA
|
67 | Compare → |
|
Halozyme Therapeutics, Inc. vs Incyte Corporation
|
83 | Compare → |
|
Halozyme Therapeutics, Inc. vs PTC Inc.
|
47 | Compare → |
|
Halozyme Therapeutics, Inc. vs Camurus AB (publ)
|
40 | Compare → |
|
Halozyme Therapeutics, Inc. vs Eli Lilly and Company
|
66 | Compare → |
|
Halozyme Therapeutics, Inc. vs Novartis AG
|
47 | Compare → |
|
Halozyme Therapeutics, Inc. vs Gen Digital Inc.
|
49 | Compare → |
|
Halozyme Therapeutics, Inc. vs Genmab A/S
|
31 | Compare → |
View the complete Halozyme Therapeutics, Inc. report including all peer dimensions.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.